Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: February 22, 2021
Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report.
Journal: Cureus
Published: April 24, 2019
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Journal: Journal of the American Academy of Dermatology
Published: May 04, 2015
Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review.
Journal: Psychosomatics
Published: September 30, 2014
Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.
Journal: Annals of surgical oncology
Published: September 01, 2013
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528.
Journal: Cancer chemotherapy and pharmacology
Published: July 31, 2013
Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors.
Journal: Anti-cancer drugs
Published: May 24, 2013
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities.
Journal: JAMA surgery
Published: April 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026